Drug intelligence / Profile preview

Sporax

Development stage
Unknown
Lead developer
Rax Health Care
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Sporax is an antibiotic brand manufactured and distributed by Rax Health Care, containing the active ingredient cephalexin. As a first-generation cephalosporin, it functions by inhibiting bacterial cell wall synthesis through the binding and inactivation of penicillin-binding proteins (PBPs), which are essential for the cross-linking of peptidoglycan layers. This disruption leads to bacterial cell lysis and death. Sporax is indicated for the treatment of various susceptible bacterial infections, including those affecting the respiratory tract, middle ear (otitis media), skin and soft tissues, bones, and the urinary tract. It is available in multiple formulations, including oral capsules and a dry syrup (which is reconstituted into an oral suspension), as well as liquid drops for oral or topical use depending on the specific product form.

Brand names
Sporax
Other names
cephalexin
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on Sporax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sporax.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call